~~<i id='452A916FC1'><strike id='452A916FC1'><tt id='452A916FC1'><pre id='452A916FC1'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

entertainment

author：comprehensive 2025-09-02 08:25:13 - browse：88737

A new Ebola epidemic in the Democratic Republic of the Congo is shaping up to be the most dangerous and difficult test of the world’s ability to contain the disease since the catastrophic West African outbreak in 2014 and 2015. What challenges are responders facing? And how might experimental vaccines be used to try to slow the spread of the epidemic?

See below for an archived chat with Helen Branswell about these issues and more.

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Disappointing trial forces Pfizer to pivot on obesity medicine plans

knowledge

leisure time

focus

explore

focus

leisure time

EmanateHealthsuedUnitedHealth'sOptum,allegingtheinsurerpushedittoagreenottocompeteforprimarycarephys

WSS

WuXi Biologics execs register to lobby as Congress comes for the company

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

How to pay for weight loss drugs and save Medicare

UnitedHealth’s Optum accused of antitrust violations in California

focus

entertainment

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How to pay for weight loss drugs and save Medicare

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Psychedelics group wrestles with new pharma identity

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Trump demands the U.S. pay no more for drugs than other countries … again

What a koala virus tells us about the human genome

Wildfire smoke exposes gaps in outdoor worker protections

HHS suspends federal funding for EcoHealth Alliance

leisure time

The EPA's new lead rule: How one expert crunched the numbers

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Oak Street deal isn't the answer to health care's woes

Lilly’s weekly insulin works as well as daily products, new studies show

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

UnitedHealth’s Optum accused of antitrust violations in California

focus

explore

focus

leisure time